Open AccessMechanistic insights into differential requirement of receptor dimerization for oncogenic activation of mutant EGFR and its clinical perspective
Author(s) -
Jeonghee Cho
Publication year - 2020
Publication title -
bmb reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.511
H-Index - 77
eISSN - 1976-670X
pISSN - 1976-6696
DOI - 10.5483/bmbrep.2020.53.3.025
Subject(s) - erbb3 , epidermal growth factor receptor , egfr inhibitors , mutant , erbb , cancer research , cyclin dependent kinase 8 , targeted therapy , gefitinib , autophosphorylation , biology , t790m , erbb4 , cancer , signal transduction , kinase , microbiology and biotechnology , gene , receptor tyrosine kinase , genetics , protein kinase a , notch signaling pathway
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom